SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-18-265001
Filing Date
2018-08-31
Accepted
2018-08-31 16:03:01
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d618080d424b5.htm 424B5 436471
2 GRAPHIC g618080g77m30.jpg GRAPHIC 31114
  Complete submission text file 0001193125-18-265001.txt   480292
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-221491 | Film No.: 181050140
SIC: 2836 Biological Products, (No Diagnostic Substances)